Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | C7R-GD2.CAR-T cells |
Synonyms | |
Therapy Description |
C7R-GD2.CAR-T cells are autologous T-cells engineered to express a constitutively active IL7R (C7R) and a chimeric antigen receptor (CAR) targeting GD2, which may have antitumor activity against GD2-expressing tumor cells (PMID: 28830878). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
C7R-GD2.CAR-T cells | IL-7 Receptor Co-expressing GD2-specific CAR T-cells | C7R-GD2.CAR-T cells are autologous T-cells engineered to express a constitutively active IL7R (C7R) and a chimeric antigen receptor (CAR) targeting GD2, which may have antitumor activity against GD2-expressing tumor cells (PMID: 28830878). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03635632 | Phase I | C7R-GD2.CAR-T cells Cyclophosphamide + Fludarabine | C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) | Active, not recruiting | USA | 0 |
NCT04099797 | Phase I | C7R-GD2.CAR-T cells Cyclophosphamide + Fludarabine | C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) | Recruiting | USA | 0 |